Similar Papers

Paper Title
Journal
Date
Author
GR 03.03 Thoracoscopic Segmentectomy for Early-Stage Lung Cancer
T D’Amico
Journal of Thoracic Oncology | VOL. 12
T D’AmicoT D’Amico
01 Nov 2017
MS07.04 Stage I (Resectable) NSCLC: Surgery
R Tanaka
Journal of Thoracic Oncology | VOL. 14
R TanakaR Tanaka
01 Oct 2019
A nonrandomized confirmatory phase III study of sublobar surgical resection for peripheral ground glass opacity dominant lung cancer defined with thoracic thin-section computed tomography (JCOG0804/WJOG4507L).
Kenji Suzuki ... Tetsuya Mitsudomi
Journal of Clinical Oncology | VOL. 35
Kenji Suzuki, et. al.Kenji Suzuki ... Tetsuya Mitsudomi
20 May 2017
MS27.04 Therapeutic Implications of AJCC 8th Edition T1 Subsets
L Donahoe
Journal of Thoracic Oncology | VOL. 13
L DonahoeL Donahoe
01 Oct 2018
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
HIV Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in Non-Small Cell Lung Cancer
Baptiste Abbar ... Brigitte Autran
Journal of Thoracic Oncology | VOL. -
Baptiste Abbar, et. al.Baptiste Abbar ... Brigitte Autran
01 Feb 2025
Meeting Announcements
-
Journal of Thoracic Oncology | VOL. 20
--
01 Feb 2025
Safety, Pharmacokinetics, and Efficacy of TY-9591 (Deuterated Osimertinib Derivative) in Advanced EGFR-mutated Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation and Dose-Expansion Study
Baohui Han ... Yusheng Wu
Journal of Thoracic Oncology | VOL. -
Baohui Han, et. al.Baohui Han ... Yusheng Wu
01 Feb 2025
First-Line Camrelizumab versus Placebo Plus Chemotherapy with or without Radiotherapy for Brain Metastases in Non-Small-Cell Lung Cancer: The CTONG 2003 Randomized Placebo-Controlled Trial
Yang-Si Li ... Yi-Long Wu
Journal of Thoracic Oncology | VOL. -
Yang-Si Li, et. al.Yang-Si Li ... Yi-Long Wu
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.